These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15162464

  • 21. Noninvasive evaluation of graft steatosis in living donor liver transplantation.
    Iwasaki M, Takada Y, Hayashi M, Minamiguchi S, Haga H, Maetani Y, Fujii K, Kiuchi T, Tanaka K.
    Transplantation; 2004 Nov 27; 78(10):1501-5. PubMed ID: 15599315
    [Abstract] [Full Text] [Related]

  • 22. Body mass index as a predictor of hepatic steatosis in living liver donors.
    Rinella ME, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M, Superina R, Flamm SL, Blei AT.
    Liver Transpl; 2001 May 27; 7(5):409-14. PubMed ID: 11349260
    [Abstract] [Full Text] [Related]

  • 23. Macrovesicular steatosis in living related liver donors: correlation of biopsy findings with CT liver attenuation index and body mass index.
    Jehangir M, Nazir R, Jang A, Rana A, Rafique S, Dar FS.
    Clin Transplant; 2016 Sep 27; 30(9):1016-20. PubMed ID: 27291347
    [Abstract] [Full Text] [Related]

  • 24. Quantitative estimation of the degree of hepatic macrovesicular steatosis in a disease-free population: a single-center experience in mainland China.
    Liu ZJ, Gong JP, Yan LN.
    Liver Transpl; 2009 Nov 27; 15(11):1605-12. PubMed ID: 19877230
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Resolution of Severe Graft Steatosis Before Living-Donor Liver Transplant After 86 Pounds of Weight Loss.
    Roubil JG, Martins PN, Babak M, Bledsoe J, Bludevich BM, Barry C, Bozorgzadeh A.
    Exp Clin Transplant; 2022 Sep 27; 20(9):874-877. PubMed ID: 32778015
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation.
    Nakamuta M, Morizono S, Soejima Y, Yoshizumi T, Aishima S, Takasugi S, Yoshimitsu K, Enjoji M, Kotoh K, Taketomi A, Uchiyama H, Shimada M, Nawata H, Maehara Y.
    Transplantation; 2005 Sep 15; 80(5):608-12. PubMed ID: 16177634
    [Abstract] [Full Text] [Related]

  • 31. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor.
    Alwayn IP, Andersson C, Zauscher B, Gura K, Nosé V, Puder M.
    Transplantation; 2005 Mar 15; 79(5):606-8. PubMed ID: 15753852
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical significance of detailed preoperative evaluation on donors in right lobe living donor liver transplantation.
    Zhang Y, Wen T, Yan L, Chen Z, Li B, Zeng Y, Zhao J, Wang W, Yang J, Xu M, Ma Y.
    Hepatogastroenterology; 2008 Mar 15; 55(86-87):1725-8. PubMed ID: 19102378
    [Abstract] [Full Text] [Related]

  • 34. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
    Hwang I, Lee JM, Lee KB, Yoon JH, Kiefer B, Han JK, Choi BI.
    Radiology; 2014 Jun 15; 271(3):730-8. PubMed ID: 24533869
    [Abstract] [Full Text] [Related]

  • 35. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival.
    Frongillo F, Avolio AW, Nure E, Mulè A, Pepe G, Magalini SC, Agnes S.
    Transplant Proc; 2009 May 15; 41(4):1268-72. PubMed ID: 19460535
    [Abstract] [Full Text] [Related]

  • 36. Use of livers with microvesicular fat safely expands the donor pool.
    Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, Miller CM, Sheiner PA.
    Transplantation; 1997 Jul 27; 64(2):248-51. PubMed ID: 9256182
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
    Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, Upton MP, Reyes JD, Perkins JD.
    Liver Transpl; 2010 Jul 27; 16(7):874-84. PubMed ID: 20583086
    [Abstract] [Full Text] [Related]

  • 39. Safety and feasibility of diet-treated donors with steatotic livers at the initial consultation for living-donor liver transplantation.
    Oshita A, Tashiro H, Amano H, Kobayashi T, Onoe T, Ide K, Takaki S, Takahashi S, Arihiro K, Chayama K, Ohdan H.
    Transplantation; 2012 May 27; 93(10):1024-30. PubMed ID: 22495493
    [Abstract] [Full Text] [Related]

  • 40. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.
    Tran TT, Changsri C, Shackleton CR, Poordad FF, Nissen NN, Colquhoun S, Geller SA, Vierling JM, Martin P.
    J Gastroenterol Hepatol; 2006 Feb 27; 21(2):381-3. PubMed ID: 16509862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.